Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Johnson and Johnson
Mallinckrodt
US Department of Justice
Teva
Novartis
Express Scripts
Deloitte
Chinese Patent Office

Generated: October 23, 2017

DrugPatentWatch Database Preview

FLOMAX Drug Profile

« Back to Dashboard

What is the patent landscape for Flomax, and what generic Flomax alternatives are available?

Flomax is a drug marketed by Boehringer Ingelheim and is included in one NDA.

The generic ingredient in FLOMAX is tamsulosin hydrochloride. There are thirty-two drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.

Summary for Tradename: FLOMAX

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list7
Bulk Api Vendors: see list113
Clinical Trials: see list37
Patent Applications: see list1,233
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLOMAX at DailyMed

Pharmacology for Tradename: FLOMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
FLOMAX
tamsulosin hydrochloride
CAPSULE;ORAL020579-001Apr 15, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FLOMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
FLOMAX
tamsulosin hydrochloride
CAPSULE;ORAL020579-001Apr 15, 1997► Subscribe► Subscribe
Boehringer Ingelheim
FLOMAX
tamsulosin hydrochloride
CAPSULE;ORAL020579-001Apr 15, 1997► Subscribe► Subscribe
Boehringer Ingelheim
FLOMAX
tamsulosin hydrochloride
CAPSULE;ORAL020579-001Apr 15, 1997► Subscribe► Subscribe
Boehringer Ingelheim
FLOMAX
tamsulosin hydrochloride
CAPSULE;ORAL020579-001Apr 15, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for FLOMAX

Drugname Dosage Strength RLD Submissiondate
tamsulosin hydrochlorideCapsules0.4 mgFlomax12/20/2004
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Moodys
Chubb
Julphar
Cerilliant
US Army
Baxter
Boehringer Ingelheim
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot